FLZ protects dopaminergic neuron through activating protein kinase B/mammalian target of rapamycin pathway and inhibiting RTP801 expression in Parkinson's disease models.

Bao, X-Q

FLZ protects dopaminergic neuron through activating protein kinase B/mammalian target of rapamycin pathway and inhibiting RTP801 expression in Parkinson's disease models. [electronic resource] - Neuroscience Jan 2012 - 396-404 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1873-7544

10.1016/j.neuroscience.2011.11.036 doi


Adaptor Proteins, Signal Transducing
Animals
Benzeneacetamides--pharmacology
Blotting, Western
Cell Line
Chromones--pharmacology
Corpus Striatum--drug effects
DNA-Binding Proteins--biosynthesis
Dopamine--metabolism
Dopaminergic Neurons--drug effects
Flow Cytometry
Immunohistochemistry
Immunoprecipitation
MPTP Poisoning--drug therapy
Male
Mice
Mice, Inbred C57BL
Morpholines--pharmacology
Movement Disorders--drug therapy
Neuroprotective Agents
Oncogene Protein v-akt--physiology
Phenols--pharmacology
Postural Balance--drug effects
Protein Kinase Inhibitors--pharmacology
Proto-Oncogene Proteins c-akt--antagonists & inhibitors
Signal Transduction--drug effects
TOR Serine-Threonine Kinases--physiology
Transcription Factors--biosynthesis
Tyrosine 3-Monooxygenase--metabolism
alpha-Synuclein--drug effects